In addition, tumors derived from CHEK1-OE cells were resistant to both ADR and BTZ, whereas WT cells were sensitive to the treatment (Fig. 7A–D), suggesting that CHEK1 induced MM drug resistance in vivo. The gene discussed is CHEK1; the disease is Miyoshi myopathy.